Researchers present Tripath: new, deep learning models that can use 3D pathology datasets to make clinical outcome predictions. The research team imaged curated prostate cancer specimens, using two 3D ...
Results of a Taiwan-based study are expected to be validated in a new collaboration with a major Japanese medical institution, assessing the higher sensitivity of 3D pathology over conventional ...
In the preliminary findings of a study conducted with the National Taiwan University Hospital, over 50% of sample cases were reclassified as HER2-expressing when 3D pathology was applied. This is a 3D ...
ARPA-H has awarded Jonathan T.C. Liu, Ph.D., University of Washington Professor and Scientific Co-Founder of Alpenglow Biosciences, a groundbreaking contract to develop a platform technology for ...
Human tissue is intricate, complex and, of course, three dimensional. But the thin slices of tissue that pathologists most often use to diagnose disease are two dimensional, offering only a limited ...
Two new research breakthroughs involving the company and its technologies make inroads into new possibilities for medicine SAN FRANCISCO, March 31, 2023 /PRNewswire/ -- JelloX Biotech Inc., a ...
HSINCHU, July 31, 2024 /PRNewswire/ -- JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to further develop ...
Tripath (far right), which utilizes 3D deep learning and the whole tissue volume, is able to outperform the current clinical baseline (far left) and 2D deep learning baselines (middle) on cancer ...
SEATTLE--(BUSINESS WIRE)--Alpenglow Biosciences, a leading 3D spatial biology company, was recently awarded contracts from Advanced Research Projects Agency for Health (ARPA-H) and the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results